Sucampo Pharmaceuticals (SCMP) 21.09 $SCMP
Uptrend Call Working As Sucampo Pharmaceuticals Stock Rises 12.4% (SCMP)
Comtex SmarTrend(R) - Thu Apr 23, 9:39AM CDT
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on April 8th, 2015 at $19.30. In approximately 2 weeks, Sucampo Pharmaceuticals has returned 12.44% as of today's recent price of $21.70.
SCMP: 21.09 (-0.31)
Sucampo Announces First Quarter 2015 Earnings Call
GlobeNewswire - Wed Apr 22, 5:45AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2015 financial results teleconference and webcast at 8:30 a.m. Eastern on Wednesday, May 6, 2015. The press release announcing the financial results and operating highlights is expected to be released before the opening of capital markets that day.
SCMP: 21.09 (-0.31)
Roche's Avastin's Label Expanded in EU for Cervical Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 12:00PM CDT
Roche Holding AG (RHHBY) received positive news when the European Commission approved yet another label expansion of its oncology drug Avastin.
ACT: 295.41 (-2.95), VRX: 210.42 (+1.03), SCMP: 21.09 (-0.31)
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 8:05AM CDT
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)?
SCMP: 21.09 (-0.31)
Nasdaq stocks posting largest percentage increases
AP - Wed Apr 08, 1:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
APTO: 6.37 (-0.01), SINA: 38.54 (+1.19), ADXS: 23.34 (-0.27), AGRX: 12.77 (+0.33), CLVS: 92.03 (+1.78), HOFT: 24.89 (-0.09), ASPS: 23.24 (+0.76), CTSO: 7.52 (+0.50), SCMP: 21.09 (-0.31), HOLI: 23.75 (-0.01), BIND: 6.84 (-0.33), APS.TO: 7.70 (-0.09)
Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
GlobeNewswire - Tue Apr 07, 5:45AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 14 Annual Needham Healthcare Conference taking place April 14, 2015 at 1:40 PM ET.
SCMP: 21.09 (-0.31)
Sucampo Pharmaceuticals
at Investor's Business Daily - Mon Apr 06, 5:41PM CDT
Sucampo Pharmaceuticals (SCMP) was initiated with a buy rating by Guggenheim. Analysts said that the biotech's pipeline and M&A could add upside to lead drug Amitiza. Shares rose 9.8% to 17.21.
SCMP: 21.09 (-0.31)
Stocks Add To Gains; Sucampo Up On New Rating
at Investor's Business Daily - Mon Apr 06, 12:25PM CDT
Stocks continued to inch higher Monday afternoon after staging a big upside reversal earlier. The S&P 500 rallied 0.9%, thanks to energy and mining stocks. The benchmark index had been off 0.5% near the open. The Nasdaq rose 0.7% and the Dow Jones...
NOW: 76.09 (-0.79), ALTR: 40.89 (-1.20), SCMP: 21.09 (-0.31), INTC: 32.08 (-0.27), EPAM: 66.61 (-0.95)
Insider Trading Alert - SCMP, SE And CNC Traded By Insiders
at The Street - Mon Apr 06, 12:00PM CDT
Stocks with insider trader activity include SCMP, SE and CNC
CNC: 73.67 (+1.13), SE: 37.79 (-0.27), SCMP: 21.09 (-0.31)
Sucampo Stock Spikes On Bullish Initiation Report
at Investor's Business Daily - Mon Apr 06, 11:57AM CDT
Hot biotech Sucampo Pharmaceuticals (SCMP) rose more than 10% in early trading Monday after Guggenheim launched coverage with a buy rating, seeing multiple growth drivers ahead. Analyst Louise Chen wrote that Sucampo's constipation drug Amitiza still...
ACT: 295.41 (-2.95), IRWD: 15.10 (-0.38), SCMP: 21.09 (-0.31)
InsiderInsights.com Daily Round Up 4/2/15: AGCO, BH, RWC, VNCE
InsiderInsights - at Seeking Alpha - Fri Apr 03, 7:27AM CDT
LBTYK: 50.95 (+0.44), OLED: 47.60 (+0.26), GMAN: 8.49 (+0.05), UNF: 117.96 (-1.38), AGCO: 48.31 (-0.56), LNG: 77.29 (-1.35), VNCE: 18.94 (-0.30), LM: 54.60 (+0.07), SNFCA: 5.60 (+0.13), K: 63.73 (-0.12), BH: 396.61 (+1.13), RCAP: 8.40 (-0.44), SCMP: 21.09 (-0.31), RWC: 6.39 (+0.04), COST: 148.12 (+0.82), SIX: 51.08 (+1.20), DAVE: 30.32 (+0.36)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 11:49AM CDT
TRVN: 6.69 (-0.30), WGO: 21.06 (+0.29), CCSC: 5.42 (-0.15), OTIV: 1.50 (-0.10), DPLO: 36.71 (+0.46), CNAT: 6.66 (-0.15), WGBS: 4.62 (+0.05), HKTV: 9.11 (+1.44), DVD: 2.39 (-0.02), SEDG: 24.89 (+0.10), ENVA: 19.33 (-0.33), SEED: 1.77 (+0.16), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), SGNT: 25.20 (-0.40), WRLD: 74.78 (-0.56), VBLT: 4.23 (+0.07), RCON: 1.90 (-0.10), SNDK: 67.92 (-0.84)
Stocks Off Morning Lows; Red Hat Up On Earnings
at Investor's Business Daily - Thu Mar 26, 11:10AM CDT
Stocks were off their session lows but still in the red near Thursday's midpoint amid conflict in the Middle East. The Nasdaq pared a 1% loss to 0.3%. The S&P 500 cut a 0.8% deficit to 0.1%. The Dow Jones industrial average was also off 0.1%. Volume...
FRSH: 17.66 (-0.27), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), FRGI: 54.90 (-4.19)
Sucampo prices equity offering
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 8:26AM CDT
SCMP: 21.09 (-0.31)
Sucampo Prices Public Offering of Common Stock by Selling Stockholders
GlobeNewswire - Thu Mar 26, 8:19AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the pricing of an underwritten public offering of 4,000,000 shares of its class A common stock by selling stockholders, offered at a price to the public of $14.00 per share for an aggregate offering of $56.0 million of class A common stock. All shares will be offered by S&R Technology Holdings, LLC, S&R Foundation, Dr. Sachiko Kuno and Dr. Ryuji Ueno. Sucampo will not sell any shares or receive any proceeds from the offering. The underwriters have been granted a 30-day option to purchase up to an aggregate of 600,000 additional shares of class A common stock. The offering is expected to close on or about March 31, 2015, subject to customary closing conditions.
SCMP: 21.09 (-0.31)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 8:13AM CDT
EXXI: 4.16 (+0.06), OTIV: 1.50 (-0.10), CNAT: 6.66 (-0.15), EXAS: 21.98 (-1.08), WGBS: 4.62 (+0.05), FIVE: 36.04 (+0.10), ROSG: 3.72 (+0.06), NVAX: 8.58 (-0.07), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), CLLS: 32.61 (-0.07), MAGS: 4.90 (unch), VBLT: 4.23 (+0.07), SNDK: 67.92 (-0.84)
Uptrend Call Working As Sucampo Pharmaceuticals Stock Rises 12.4% (SCMP)
Comtex SmarTrend(R) - Thu Apr 23, 9:39AM CDT
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on April 8th, 2015 at $19.30. In approximately 2 weeks, Sucampo Pharmaceuticals has returned 12.44% as of today's recent price of $21.70.
SCMP: 21.09 (-0.31)
Sucampo Announces First Quarter 2015 Earnings Call
GlobeNewswire - Wed Apr 22, 5:45AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2015 financial results teleconference and webcast at 8:30 a.m. Eastern on Wednesday, May 6, 2015. The press release announcing the financial results and operating highlights is expected to be released before the opening of capital markets that day.
SCMP: 21.09 (-0.31)
Roche's Avastin's Label Expanded in EU for Cervical Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 12:00PM CDT
Roche Holding AG (RHHBY) received positive news when the European Commission approved yet another label expansion of its oncology drug Avastin.
ACT: 295.41 (-2.95), VRX: 210.42 (+1.03), SCMP: 21.09 (-0.31)
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 09, 8:05AM CDT
Can The Uptrend Continue for Sucampo Pharmaceuticals (SCMP)?
SCMP: 21.09 (-0.31)
Nasdaq stocks posting largest percentage increases
AP - Wed Apr 08, 1:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
APTO: 6.37 (-0.01), SINA: 38.54 (+1.19), ADXS: 23.34 (-0.27), AGRX: 12.77 (+0.33), CLVS: 92.03 (+1.78), HOFT: 24.89 (-0.09), ASPS: 23.24 (+0.76), CTSO: 7.52 (+0.50), SCMP: 21.09 (-0.31), HOLI: 23.75 (-0.01), BIND: 6.84 (-0.33), APS.TO: 7.70 (-0.09)
Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
GlobeNewswire - Tue Apr 07, 5:45AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 14 Annual Needham Healthcare Conference taking place April 14, 2015 at 1:40 PM ET.
SCMP: 21.09 (-0.31)
Sucampo Pharmaceuticals
at Investor's Business Daily - Mon Apr 06, 5:41PM CDT
Sucampo Pharmaceuticals (SCMP) was initiated with a buy rating by Guggenheim. Analysts said that the biotech's pipeline and M&A could add upside to lead drug Amitiza. Shares rose 9.8% to 17.21.
SCMP: 21.09 (-0.31)
Stocks Add To Gains; Sucampo Up On New Rating
at Investor's Business Daily - Mon Apr 06, 12:25PM CDT
Stocks continued to inch higher Monday afternoon after staging a big upside reversal earlier. The S&P 500 rallied 0.9%, thanks to energy and mining stocks. The benchmark index had been off 0.5% near the open. The Nasdaq rose 0.7% and the Dow Jones...
NOW: 76.09 (-0.79), ALTR: 40.89 (-1.20), SCMP: 21.09 (-0.31), INTC: 32.08 (-0.27), EPAM: 66.61 (-0.95)
Insider Trading Alert - SCMP, SE And CNC Traded By Insiders
at The Street - Mon Apr 06, 12:00PM CDT
Stocks with insider trader activity include SCMP, SE and CNC
CNC: 73.67 (+1.13), SE: 37.79 (-0.27), SCMP: 21.09 (-0.31)
Sucampo Stock Spikes On Bullish Initiation Report
at Investor's Business Daily - Mon Apr 06, 11:57AM CDT
Hot biotech Sucampo Pharmaceuticals (SCMP) rose more than 10% in early trading Monday after Guggenheim launched coverage with a buy rating, seeing multiple growth drivers ahead. Analyst Louise Chen wrote that Sucampo's constipation drug Amitiza still...
ACT: 295.41 (-2.95), IRWD: 15.10 (-0.38), SCMP: 21.09 (-0.31)
InsiderInsights.com Daily Round Up 4/2/15: AGCO, BH, RWC, VNCE
InsiderInsights - at Seeking Alpha - Fri Apr 03, 7:27AM CDT
LBTYK: 50.95 (+0.44), OLED: 47.60 (+0.26), GMAN: 8.49 (+0.05), UNF: 117.96 (-1.38), AGCO: 48.31 (-0.56), LNG: 77.29 (-1.35), VNCE: 18.94 (-0.30), LM: 54.60 (+0.07), SNFCA: 5.60 (+0.13), K: 63.73 (-0.12), BH: 396.61 (+1.13), RCAP: 8.40 (-0.44), SCMP: 21.09 (-0.31), RWC: 6.39 (+0.04), COST: 148.12 (+0.82), SIX: 51.08 (+1.20), DAVE: 30.32 (+0.36)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 11:49AM CDT
TRVN: 6.69 (-0.30), WGO: 21.06 (+0.29), CCSC: 5.42 (-0.15), OTIV: 1.50 (-0.10), DPLO: 36.71 (+0.46), CNAT: 6.66 (-0.15), WGBS: 4.62 (+0.05), HKTV: 9.11 (+1.44), DVD: 2.39 (-0.02), SEDG: 24.89 (+0.10), ENVA: 19.33 (-0.33), SEED: 1.77 (+0.16), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), SGNT: 25.20 (-0.40), WRLD: 74.78 (-0.56), VBLT: 4.23 (+0.07), RCON: 1.90 (-0.10), SNDK: 67.92 (-0.84)
Stocks Off Morning Lows; Red Hat Up On Earnings
at Investor's Business Daily - Thu Mar 26, 11:10AM CDT
Stocks were off their session lows but still in the red near Thursday's midpoint amid conflict in the Middle East. The Nasdaq pared a 1% loss to 0.3%. The S&P 500 cut a 0.8% deficit to 0.1%. The Dow Jones industrial average was also off 0.1%. Volume...
FRSH: 17.66 (-0.27), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), FRGI: 54.90 (-4.19)
Sucampo prices equity offering
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 8:26AM CDT
SCMP: 21.09 (-0.31)
Sucampo Prices Public Offering of Common Stock by Selling Stockholders
GlobeNewswire - Thu Mar 26, 8:19AM CDT
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced the pricing of an underwritten public offering of 4,000,000 shares of its class A common stock by selling stockholders, offered at a price to the public of $14.00 per share for an aggregate offering of $56.0 million of class A common stock. All shares will be offered by S&R Technology Holdings, LLC, S&R Foundation, Dr. Sachiko Kuno and Dr. Ryuji Ueno. Sucampo will not sell any shares or receive any proceeds from the offering. The underwriters have been granted a 30-day option to purchase up to an aggregate of 600,000 additional shares of class A common stock. The offering is expected to close on or about March 31, 2015, subject to customary closing conditions.
SCMP: 21.09 (-0.31)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 8:13AM CDT
EXXI: 4.16 (+0.06), OTIV: 1.50 (-0.10), CNAT: 6.66 (-0.15), EXAS: 21.98 (-1.08), WGBS: 4.62 (+0.05), FIVE: 36.04 (+0.10), ROSG: 3.72 (+0.06), NVAX: 8.58 (-0.07), RHT: 76.83 (-0.02), SCMP: 21.09 (-0.31), CLLS: 32.61 (-0.07), MAGS: 4.90 (unch), VBLT: 4.23 (+0.07), SNDK: 67.92 (-0.84)
